NovellusDx: Funding, Investors & Team (Oct 2026)
Novellusdx develops tumor specific driver mutations.
NovellusDx has raised $57.0M across 1 funding round on record, the most recent an undisclosed round of $57.0M announced in Sep 2020.
That round is above the $14M median round size for Israel companies tracked on FundedIQ over the last two years.
NovellusDx Company Profile and Key Stats
Latest funding round on record: Sep 2020.
NovellusDx Funding Rounds
NovellusDx Founders and Leadership Team
Contact details for the NovellusDx team: 1 of 1 has an email address on file.
Start 14-day free trial →NovellusDx Funding in Context
NovellusDx's latest round of $57.0M is above the median round in Israel. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NovellusDx in Biotechnology and Jerusalem
Companies Similar to NovellusDx
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and…
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune…
HyperGuest’s technology platform empowers hotels and travel providers to deliver rooms with maximum…
Rig Security focuses on identity security and protection across human, machine, service, bot, and AI-agent…
UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and…
Loora is an artificial intelligence company that develops an AI-powered English language learning platform…
Keewano develops a database and analytics platform for machine reasoning over complete event sequences.
Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform…
Guardio is a cyber security company. Guardio is a lightweight extension designed that helps to browse quickly…
Platform enabling enterprises to create, test, and deploy AI agents for voice, chat, and email.
Aitan is an advanced edge-AI robotic weapon systems developer for defense.
Huskeys is a cybersecurity company that develops an edge security management (ESM) platform designed to…
NovellusDx Funding FAQs
What does NovellusDx do?
Novellusdx develops tumor specific driver mutations.
How much funding has NovellusDx raised?
NovellusDx has raised $57.0M across 1 round on record. The most recent is an undisclosed round of $57.0M announced in Sep 2020.
When did NovellusDx last raise funding?
NovellusDx's most recent funding round on record is an undisclosed round of $57.0M, announced in Sep 2020.
Who is the CEO of NovellusDx?
Haim Gil is listed as CEO at NovellusDx.
Where is NovellusDx headquartered?
NovellusDx is based in Jerusalem, N/A, Israel.
How many employees does NovellusDx have?
NovellusDx is in the 51-100 employee band.
About FundedIQ's NovellusDx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NovellusDx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.